Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma
Article in Hepatology International (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Efficacy of lenvatinib versus sorafenib in the primary treatment of advanced hepatocellular carcinoma: A meta‐analysis
Article in JGH Open (December 2023)
Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma treatment: a systematic review and meta-analysis of real-world study
Article in European Journal of Gastroenterology & Hepatology (November 2023)